Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2026-07-02 16:03:16 ET · period of report 2026-07-01 · accession 0001439222-26-000110 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-07-02 16:03 | 2026-07-01 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $0.00 | +8,375 | 88.7K | +10% | $0 |
| DT | 2026-07-02 16:03 | 2026-07-01 | AGIO | Gheuens Sarah | Chief Medical Off | S - Sale+OE | $37.56 | -4,007 | 84.6K | -5% | -$150.5K |
| DT | 2026-07-02 16:03 | 2026-07-01 | AGIO | Gheuens Sarah | Chief Medical Off | M - OptEx | $0.00 | -8,375 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2026-07-01 | M | A | 8,375 | $0.00 | 88,652 | D | — | — | |
| 2 | Common | Common stock | 2026-07-01 | S | D | 4,007 | $37.56 | 84,645 | D | — | — | (F1) Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated July 1, 2023. |
| 3 | Derivative | Restricted stock units | 2026-07-01 | M | D | 8,375 | $0.00 | 0 | D | — · — to — | 8,375 Common stock | (F2) Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. (F3) The restricted stock units were granted on July 1, 2023. Beginning on July 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. (F3) The restricted stock units were granted on July 1, 2023. Beginning on July 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments. |